Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord MSCs + Liraglutide in T2DM
NCT01954147Phase 2Unknown
- Sponsor
- Diabetes Care Center of Nanjing Military Command
- Start
- Oct 2013
- Primary completion
- Oct 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus (T2DM), sponsored by Diabetes Care Center of Nanjing Military Command. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01954147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01954147.